v3.26.1
Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Significant components of general and administrative (G&A) expenses:    
Total operating expenses $ 9,281 $ 5,021
Loss from operations (9,281) (5,021)
Total other income, net 0 230
Net loss (9,243) (4,711)
Reportable Segment    
Significant components of research and development (R&D) expenses:    
Clinical trial expenses 747 370
Manufacturing and related process development expenses 507 414
Personnel-related expenses 3,271 1,981
Significant components of general and administrative (G&A) expenses:    
Public company-related expenses 3,016 1,200
Personnel-related expenses 1,230 737
Intellectual property expenses 302 107
All other R&D and G&A expenses 208 212
Total operating expenses 9,281 5,021
Loss from operations (9,281) (5,021)
Total other income, net 38 310
Net loss $ (9,243) $ (4,711)